UNICA IRIS Institutional Research Information System

KOWALIK, MARTA ANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 94.946
NA - Nord America 4.172
AS - Asia 1.953
SA - Sud America 250
Continente sconosciuto - Info sul continente non disponibili 198
AF - Africa 77
OC - Oceania 4
Totale 101.600
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 93.832
US - Stati Uniti d'America 4.075
SG - Singapore 728
CN - Cina 586
SE - Svezia 275
VN - Vietnam 213
BR - Brasile 188
DE - Germania 184
UA - Ucraina 147
GB - Regno Unito 121
FI - Finlandia 117
FR - Francia 84
BD - Bangladesh 77
CA - Canada 63
HK - Hong Kong 58
IN - India 43
TR - Turchia 41
KR - Corea 37
ZA - Sudafrica 31
NL - Olanda 27
PL - Polonia 26
IQ - Iraq 24
AR - Argentina 21
BE - Belgio 20
JP - Giappone 19
MA - Marocco 19
RU - Federazione Russa 19
IR - Iran 18
MX - Messico 17
ES - Italia 15
PK - Pakistan 15
AT - Austria 14
IE - Irlanda 11
JO - Giordania 11
EC - Ecuador 10
CO - Colombia 9
MY - Malesia 9
CH - Svizzera 8
LT - Lituania 8
ID - Indonesia 7
PH - Filippine 7
UZ - Uzbekistan 7
VE - Venezuela 7
IL - Israele 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
DK - Danimarca 5
EG - Egitto 5
MT - Malta 5
PE - Perù 5
TN - Tunisia 5
TW - Taiwan 5
AZ - Azerbaigian 4
DZ - Algeria 4
HU - Ungheria 4
JM - Giamaica 4
KE - Kenya 4
KZ - Kazakistan 4
PA - Panama 4
PT - Portogallo 4
AU - Australia 3
CZ - Repubblica Ceca 3
LK - Sri Lanka 3
NG - Nigeria 3
PS - Palestinian Territory 3
PY - Paraguay 3
AL - Albania 2
AM - Armenia 2
BY - Bielorussia 2
ET - Etiopia 2
GE - Georgia 2
GR - Grecia 2
KH - Cambogia 2
MU - Mauritius 2
NO - Norvegia 2
OM - Oman 2
PR - Porto Rico 2
RO - Romania 2
TH - Thailandia 2
AW - Aruba 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CG - Congo 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GH - Ghana 1
GT - Guatemala 1
HN - Honduras 1
IM - Isola di Man 1
KW - Kuwait 1
KY - Cayman, isole 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
NP - Nepal 1
Totale 101.396
Salva come PNG Salva come JPEG
Città #
Cagliari 91.893
Uta 1.594
Ashburn 461
Singapore 456
Fairfield 328
San Jose 286
Woodbridge 216
Chandler 202
Nyköping 180
Boardman 167
Houston 161
Los Angeles 154
Ann Arbor 150
Beijing 128
Seattle 123
Dallas 116
Wilmington 115
Cambridge 106
Council Bluffs 83
Dearborn 82
Helsinki 79
Santa Clara 78
New York 70
Jacksonville 65
The Dalles 64
Hong Kong 56
Hanoi 49
Ho Chi Minh City 48
Lauterbourg 44
Shanghai 43
Hefei 42
Nanjing 31
Seoul 31
Frankfurt am Main 29
Dong Ket 28
London 28
Milan 28
Munich 25
Buffalo 24
Redwood City 23
Warsaw 23
Boston 22
Chicago 22
Rome 22
Brussels 20
Columbus 20
São Paulo 20
Toronto 20
Kocaeli 19
San Mateo 19
Guangzhou 18
Johannesburg 18
Montreal 18
San Diego 18
Phoenix 17
Stockholm 17
Atlanta 16
Redondo Beach 16
Chennai 15
Denver 15
Orem 15
Casablanca 13
Pisa 13
Brooklyn 12
Da Nang 12
Falls Church 12
Haiphong 12
Nuremberg 12
Turku 12
Amsterdam 11
Jiaxing 11
Mountain View 11
Amman 10
Bari 10
Nanchang 10
Tokyo 10
Changsha 9
Dublin 9
Vienna 9
Baghdad 8
Dhaka 8
Manchester 8
Rio de Janeiro 8
Shenyang 8
Shenzhen 8
Tianjin 8
Washington 8
Augusta 7
Biên Hòa 7
Bogazici 7
Düsseldorf 7
Florence 7
Leawood 7
Milwaukee 7
Norwalk 7
Poplar 7
Pune 7
Auburn Hills 6
Ferrara 6
Lappeenranta 6
Totale 98.626
Salva come PNG Salva come JPEG
Nome #
Thyroid hormone receptor ligands induce regression of rat preneoplastic liver lesions causing their reversion to a differentiated phenotype 6.022
Expression of c-jun is not mandatory for mouse hepatocyte proliferation induced by two nuclear receptor ligands: TCPOBOP and T3 4.979
Statistical health monitoring applied to a metabolomic study of experimental hepatocarcinogenesis: an alternative approach to supervised methods for the identification of false positives 4.272
Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice 4.247
YAP activation is an early event and a potential therapeutic target in liver cancer development 4.069
Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats 3.969
Local hypothyroidism favors the progression of preneoplastic lesions to hepatocellular carcinoma in rats 3.887
TRbeta is the critical thyroid hormone receptor isoform in T3-induced proliferation of hepatocytes and pancreatic acinar cells 3.767
Cytokeratin-19 positivity is acquired along cancer progression and does not predict cell origin in rat hepatocarcinogenesis 3.716
Nrf2, but not β-catenin, mutation represents an early event in rat hepatocarcinogenesis 3.671
Emerging role of the pentose phosphate pathway in hepatocellular carcinoma 3.594
Global gene expression profile of normal and regenerating liver in young and old mice 3.573
Transcription profiling by array of mouse liver from TCPOBOP treated wild type and c-jun conditional knockout animals. 3.488
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis 3.208
MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC). 3.181
Induction of autophagy promotes the growth of early preneoplastic rat liver nodules 3.103
Reply to: "YAP in tumorigenesis: Friend or foe?" 2.772
High frequency of β-catenin mutations in mouse hepatocellular carcinomas induced by a nongenotoxic constitutive androstane receptor agonist 2.655
Reply to: Clinical correlation of miR-375 and alpha-fetoprotein in hepatocellular carcinoma: comparison in mice and humans 2.365
Accelerated entry into S phase and increased hepatocyte proliferation in c-jun conditional knock-out mice following administration of the CAR agonist TCPOBOP 2.355
Thyroid hormones, thyromimetics and their metabolites in the treatment of liver disease 2.337
Gender-specific interplay of signaling through β-catenin and CAR in the regulation of xenobiotic-induced hepatocyte proliferation 2.138
Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience 2.029
Animal models: A useful tool to unveil metabolic changes in hepatocellular carcinoma 1.675
Early metabolic changes in a liver carcinogenesis model 1.511
Design, synthesis and biological evaluation of novel TRβ selective agonists sustained by ADME-toxicity analysis 1.464
Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection 1.461
Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming 1.224
Early Metabolic Changes in preneoplastc nodules of the liver 1.184
Potential role of two novel agonists of thyroid hormone receptor-β on liver regeneration 977
Tg68, a novel thyroid hormone receptor‐β agonist for the treatment of NAFLD 973
Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC 912
The density of hepatic autonomic innervation differs between compensatory and direct hyperplasia rat models 883
The double-sided of human leukocyte antigen-G molecules in type 1 autoimmune hepatitis 875
Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis 854
Effect of the ligands of thyroid hormone receptor on non-alcoholic fatty liver disease 850
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 755
mRNA-miRNA networks identify metabolic pathways associated to the anti-tumorigenic effect of thyroid hormone on preneoplastic nodules and hepatocellular carcinoma 711
Delta-globin gene expression improves sickle cell disease in a humanised mouse model 678
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 615
Multi-Organ Morphological Findings in a Humanized Murine Model of Sickle Cell Trait 533
Diverse MicroRNAs-mRNA networks regulate the priming phase of mouse liver regeneration and of direct hyperplasia 531
THYROID HORMONE INHIBITS HEPATOCELLULAR CARCINOMA (HCC) DEVELOPMENT BY INTERFERING WITH THE METABOLIC PROFILE OF CANCER CELLS 486
Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma 482
Characterization Of Early Stage Metabolic Perturbations In A Rat Model Of Hepatocellular Carcinogenesis 443
Novel thyroid hormone receptor beta agonist TG68 safely induces hepatic fat loss reduction in a NASH mouse model 434
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 434
Potential use of TG68 - A novel thyromimetic - for the treatment of non-alcoholic fatty liver (NAFLD)-associated hepatocarcinogenesis 386
Metabolic reprogramming in Nrf2-driven proliferation of normal rat hepatocytes 339
Galectin-3 inhibition ameliorates hepatic steatosis in a multilineage 3D spheroid model 201
Estrogen-dependent activation of TRX2 reverses oxidative stress and metabolic dysfunction associated with steatotic disease 149
Lead induces cell-autonomous proliferation and metabolic reprogramming of hepatocytes 125
The role of OSM/OSMRβ axis in shaping the tumor microenvironment favoring MASLD-related HCC immune evasion 47
Mapping the Binding Landscape of Allosteric Inhibitor G6PDi-1 on Human G6PD 11
Totale 101.600
Salva come PNG Salva come JPEG
Categoria #
all - tutte 124.634
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 124.634
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.558 0 352 233 343 519 371 210 192 545 575 609 609
2022/20237.951 462 877 1.022 712 636 885 514 464 527 651 792 409
2023/20247.638 475 253 275 387 737 1.172 1.336 688 354 446 638 877
2024/202521.115 7.396 7.556 1.492 1.484 689 893 981 78 128 125 130 163
2025/20264.799 349 205 343 374 451 302 1.250 249 263 534 310 169
2026/2027338 172 166 0 0 0 0 0 0 0 0 0 0
Totale 101.600